• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Pfizer Inc. (PFE)

    32.71 Down 0.20(0.61%) 4:01PM EDT
    |After Hours : 32.70 Down 0.01 (0.03%) 4:53PM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    Pfizer Inc.
    235 East 42nd Street
    New York, NY 10017
    United States - Map
    Phone: 212-733-2323
    Website: http://www.pfizer.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops, registers, and commercializes medicines for various therapeutic areas, including inflammation, cardiovascular/metabolic, neuroscience and pain, rare diseases, and women’s/men’s health. The VOC segment develops and commercializes vaccines, as well as products for oncology. It also provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control brand; respiratory products under the brand names of Robitussin, Advil Cold & Sinus, Advil Congestion Relief, and Dimetapp; and personal care products under the ChapStick and Preparation H brands. The GEP segment offers patent-protected products that have lost marketing exclusivity in various markets; and generic pharmaceuticals, and sterile injectable and biosimilar development products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has strategic collaboration with KineMed Inc.; collaborations with BIND Therapeutics, Inc., Merck KGaA, and Syndax Pharmaceuticals, Inc.; research collaboration with Schrödinger, Inc.; license and collaboration agreement with Servier; strategic drug discovery agreement with Heptares; and collaboration agreement with Portola Pharmaceuticals Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Pfizer Inc.

    Corporate Governance 
    Pfizer Inc.’s ISS Governance QuickScore as of Apr 1, 2016 is 3. The pillar scores are Audit: 2; Board: 2; Shareholder Rights: 2; Compensation: 5.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Ian C. Read , 62
    Chairman, Chief Exec. Officer and Chairman of Exec. Committee
    Mr. Frank A. D'Amelio , 59
    Chief Financial Officer and Exec. VP of Bus. Operations
    Dr. Mikael Dolsten M.D., Ph.D., 57
    Pres of Worldwide R&D
    Mr. John D. Young , 51
    Group Pres of Global Established Pharma Bus.
    Dr. Michael D. Ehlers M.D., Ph.D.,
    Chief Scientific Officer for Neuroscience Research, Group Sr. VP, Head of Biotherapeutics R&D and Site Head for Cambridge & Boston, Massachusetts Locations
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders